Summary
The effects of kainic acid lesions and chronic haloperidol treatment on rat striatal dopaminergic presynaptic receptors were studied. Following the γ-butyrolactone-induced inhibition of dopaminergic impulse flow, and after dopa decarboxylase inhibition, dopa accumulation and its reversal by dopamine agonists was measured in vivo.3H-apomorphine (a dopamine receptor ligand with purported presynaptic specificity) was used for in vitro binding experiments. Presynaptic dopamine receptors, as assessed by both methods, were unaffected by intrastriatal kainic acid injection 5–6 days before sacrifice. Seven days after termination of chronic haloperidol treatment (28 days, 0.5 mg/kg/day s.c.) both an increased apomorphine response using the dopa accumulation method and an increase in3H-apomorphine binding were observed, indicating the development of presynaptic dopamine receptor supersensitivity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asper, H., Baggiolini, M., Burki, H. R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptics: Catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur. J. Pharmacol.22, 287–294 (1973)
Bacopoulos, N. G., Spokes, E. G., Bird, E. D., Roth, R. H.: Antipsychotic drug action in schizophrenic patients: Effect on cortical dopamine metabolism after long-term treatment. Science205, 1405–1407 (1979)
Baldessarini, R. J., Tarsy, D.: Mechanisms underlying tardive dyskinesia. In: The basal ganglia (M. D. Yahr, ed.), pp. 433–446. New York: Raven Press 1976
Bunney, B. S., Aghajanian, G. K.:d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Naunyn-Schmiedeberg's Arch. Pharmacol.304, 255–261 (1978)
Bunney, B. S., Grace, A. A.: Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci.23, 1715–1728 (1978)
Bunney, B. S., Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther.185, 560–571 (1973)
Coyle, J. T., Schwarcz, R.: Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature263, 244–246 (1976)
Creese, I., Snyder, S. H.: Multiple dopamine receptors. In: Catecholamines: Basic and clinical frontiers, Vol. 1 (E. Usdin, I. J. Kopin, J. D. Barchas, eds), pp. 601–603. New York: Pergamon Press 1979
Creese, I., Snyder, S. H.: Nigrostriatal lesions enhance striatal3H-apomorphine and3H-spiroperidol binding. Eur. J. Pharmacol.56, 277–281 (1979)
DiChiara, G., Porceddu, M. L., Vargiu, L., Stefanini E., Gessa, G. L.: Evidence for selective and long-lasting stimulation of “regulatory” dopamine-receptors by bromocryptine (CB154). Naunyn-Schmiedeberg's Arch. Pharmacol.300, 239–245 (1977)
Fields, J. Z., Reisine, T. D., Yamamura, H. I.: Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection. Life Sci.23, 569–574 (1978)
Gallager, D. W., Pert, A., Bunney, W. E., Jr.: Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature273, 309–312 (1978)
Gianutsos, G., Hynes, M. D., Lal, H.: Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol. Biochem. Pharmacol.24, 581–582 (1975)
Gianutsos, G., Thornburg, J. E., Moore, K. E.: Differential actions of dopamine agonists on the γ-butyrolactone-induced increase in mouse brain dopamine. Psychopharmacol.50, 225–229 (1976)
Govoni, S., Spano, P. F., Trabucchi, M.:3H-Haloperidol and3H-spiroperidol binding in rat striatum during aging. J. Pharm. Pharmacol.30, 448–449 (1978)
Kebabian, J. W., Calne, D. B.: Multiple receptors for dopamine. Nature277, 93–96 (1979)
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (dopa) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.274, 273–280 (1972)
Klein, D. E., Davis, J. M.: Diagnosis and drug treatment of psychiatric disorders. Baltimore: The Williams and Wilkens Company 1969
List, S. J., Seeman, P.: Dopamine agonists reverse the elevated3H-neuroleptic binding in neuroleptic-pretreated rats. Life Sci.24, 1447–1452 (1979)
Muller, P., Seeman, P.: Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors. Life Sci.21, 1754–1758 (1977)
Muller, P., Seeman, P.: Dopaminergic sensitivity after neuroleptics: Time course and specificity. Psychopharmacology60, 1–11 (1978)
Nagy, J. I., Lee, T., Seeman, P., Fibiger, H. C.: Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature274, 278–281 (1978)
Nowycky, M. C., Roth, R. H.: Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate. Naunyn-Schmiedeberg's Arch. Pharmacol.300, 247–254 (1977)
Nowycky, M. C., Roth, R. H.: Dopaminergic neurons: Role of presynaptic receptors in the regulation of transmitter biosynthesis. Prog. Neuro-Psychopharmacol.2, 139–158 (1978)
Scatton, B.: Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur. J. Pharmacol.46, 363–369 (1977)
Schwarcz, R., Creese, I., Coyle, J. T., Snyder, S. H.: Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature271, 766–768 (1978)
Skirboll, L. R., Grace, A. A., Bunney, B. S.: Dopamine auto- and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists. Science206, 80–82 (1979)
Seeman, P., Lee, T., Chau-Wong, M., Tedesco, J., Wong, K.: Dopamine receptors in human and calf brains using3H-apomorphine and an antipsychotic drug. Proc. Natl. Acad. Sci. USA73, 4354–4358 (1976)
Starke, K., Taube, H. D., Borowski, E.: Presynaptic receptor systems in catecholaminergic transmission. Biochem. Pharmacol.26, 259–268 (1977)
Strömbom, U.: Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation on mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol.292, 167–176 (1976)
Walters, J. R., Roth, R. H.: Dopaminergic neurons: Drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J. Pharmacol. Exp. Ther.191, 82–91 (1974)
Walters, J. R., Roth, R. H.: Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol.296, 5–14 (1976)
Weinreich, P., Lee, T., Seeman, P.: Striatal interdependence and pre-and postsynaptic dopamine receptors. Soc. Neurosci. Abstr., Vol. 8, p. 524, 1978
Wheeler, S. C., Roth, R. H.: Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. (in press 1980)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bannon, M.J., Bunney, E.B., Zigun, J.R. et al. Presynaptic dopamine receptors: Insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol. Naunyn-Schmiedeberg's Arch. Pharmacol. 312, 161–165 (1980). https://doi.org/10.1007/BF00569725
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00569725